Reduction in rabbit serum and pulmonary angiotensin converting enzyme activity after subacute bleomycin treatment.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002216:Captopril / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D003864:Depression, Chemical; D006025:Glycosaminoglycans / Q000378:metabolism; D006909:Hydroxyproline / Q000378:metabolism; D008168:Lung / Q000201:enzymology* / Q000648:ultrastructure; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D011817:Rabbits
D000903:Antibiotics, Antineoplastic; D006025:Glycosaminoglycans; D011506:Proteins; D001761:Bleomycin; D004247:DNA; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D006909:Hydroxyproline